- Home
- CRAI vs CLDX Comparison
CRAI vs CLDX Comparison
Compare CRAI & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRAI
- CLDX
- Stock Information
- Founded
- CRAI 1965
- CLDX N/A
- Country
- CRAI United States
- CLDX United States
- Employees
- CRAI N/A
- CLDX N/A
- Industry
- CRAI Other Consumer Services
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- CRAI Consumer Discretionary
- CLDX Health Care
- Exchange
- CRAI Nasdaq
- CLDX Nasdaq
- Market Cap
- CRAI 1.1B
- CLDX 1.2B
- IPO Year
- CRAI 1998
- CLDX 2008
- Fundamental
- Price
- CRAI $163.23
- CLDX $19.44
- Analyst Decision
- CRAI Buy
- CLDX Buy
- Analyst Count
- CRAI 1
- CLDX 8
- Target Price
- CRAI $224.00
- CLDX $54.29
- AVG Volume (30 Days)
- CRAI 43.3K
- CLDX 856.2K
- Earning Date
- CRAI 05-01-2025
- CLDX 05-05-2025
- Dividend Yield
- CRAI 1.19%
- CLDX N/A
- EPS Growth
- CRAI 25.05
- CLDX N/A
- EPS
- CRAI 6.74
- CLDX N/A
- Revenue
- CRAI $687,414,000.00
- CLDX $7,020,000.00
- Revenue This Year
- CRAI $6.59
- CLDX N/A
- Revenue Next Year
- CRAI $4.80
- CLDX N/A
- P/E Ratio
- CRAI $24.37
- CLDX N/A
- Revenue Growth
- CRAI 10.17
- CLDX 1.99
- 52 Week Low
- CRAI $133.54
- CLDX $14.40
- 52 Week High
- CRAI $214.01
- CLDX $47.00
- Technical
- Relative Strength Index (RSI)
- CRAI 40.20
- CLDX 54.30
- Support Level
- CRAI $160.14
- CLDX $17.45
- Resistance Level
- CRAI $168.00
- CLDX $20.36
- Average True Range (ATR)
- CRAI 7.05
- CLDX 1.21
- MACD
- CRAI 0.16
- CLDX 0.44
- Stochastic Oscillator
- CRAI 35.34
- CLDX 81.21
About CRAI CRA International Inc.
CRA International Inc is a U.S.-based advisory firm that provides economic, financial, and management consultancy services. The company advises clients on economic and financial issues relating to litigation and regulatory proceedings and helps businesses set important business strategies and solve performance-related issues. The company's clients include domestic and foreign companies, government agencies, public and private utilities, and national and international trade associations. CRA International generates majority of its revenue from the United States, while it also has its presence in United Kingdom and Other Countries.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.